• Treffer 9 von 18
Zurück zur Trefferliste

Test-retest repeatability of organ uptake on PSMA‐targeted 18F‐DCFPyL PET/CT in patients with prostate cancer

  • Objectives We evaluated 18F-DCFPyL test–retest repeatability of uptake in normal organs. Methods Twenty-two prostate cancer (PC) patients underwent two 18F-DCFPyL PET scans within 7 days within a prospective clinical trial (NCT03793543). In both PET scans, uptake in normal organs (kidneys, spleen, liver, and salivary and lacrimal glands) was quantified. Repeatability was determined by using within-subject coefficient of variation (wCOV), with lower values indicating improved repeatability. Results For SUVmean, repeatability was high for kidneys, spleen, liver, and parotid glands (wCOV, range: 9.0%–14.3%) and lower for lacrimal (23.9%) and submandibular glands (12.4%). For SUVmax, however, the lacrimal (14.4%) and submandibular glands (6.9%) achieved higher repeatability, while for large organs (kidneys, liver, spleen, and parotid glands), repeatability was low (range: 14.1%–45.2%). Conclusion We found acceptable repeatability of uptake on 18F-DCFPyL PET for normalObjectives We evaluated 18F-DCFPyL test–retest repeatability of uptake in normal organs. Methods Twenty-two prostate cancer (PC) patients underwent two 18F-DCFPyL PET scans within 7 days within a prospective clinical trial (NCT03793543). In both PET scans, uptake in normal organs (kidneys, spleen, liver, and salivary and lacrimal glands) was quantified. Repeatability was determined by using within-subject coefficient of variation (wCOV), with lower values indicating improved repeatability. Results For SUVmean, repeatability was high for kidneys, spleen, liver, and parotid glands (wCOV, range: 9.0%–14.3%) and lower for lacrimal (23.9%) and submandibular glands (12.4%). For SUVmax, however, the lacrimal (14.4%) and submandibular glands (6.9%) achieved higher repeatability, while for large organs (kidneys, liver, spleen, and parotid glands), repeatability was low (range: 14.1%–45.2%). Conclusion We found acceptable repeatability of uptake on 18F-DCFPyL PET for normal organs, in particular for SUVmean in the liver or parotid glands. This may have implications for both PSMA-targeted imaging and treatment, as patient selection for radioligand therapy and standardized frameworks for scan interpretation (PROMISE, E-PSMA) rely on uptake in those reference organs.zeige mehrzeige weniger

Volltext Dateien herunterladen

Metadaten exportieren

Statistik

Anzahl der Zugriffe auf dieses Dokument

Weitere Dienste

Teilen auf Twitter Suche bei Google Scholar
Metadaten
Verfasserangaben:Rudolf A. Werner, Susanne Lütje, Bilêl Habacha, Lena Bundschuh, Takahiro Higuchi, Andreas K. Buck, Aleksander Kosmala, Constantin LapaORCiDGND, Markus Essler, Martin A. Lodge, Kenneth J. Pienta, Mario A. Eisenberger, Mark C. Markowski, Michael A. Gorin, Martin G. Pomper, Steven P. Rowe, Ralph Alexander Bundschuh
URN:urn:nbn:de:bvb:384-opus4-1067145
Frontdoor-URLhttps://opus.bibliothek.uni-augsburg.de/opus4/106714
ISSN:0270-4137OPAC
ISSN:1097-0045OPAC
Titel des übergeordneten Werkes (Englisch):The Prostate
Verlag:Wiley-Blackwell
Verlagsort:Hoboken, NJ
Typ:Wissenschaftlicher Artikel
Sprache:Englisch
Jahr der Erstveröffentlichung:2023
Veröffentlichende Institution:Universität Augsburg
Datum der Freischaltung in OPUS:17.08.2023
Freies Schlagwort / Tag:Oncology; Urology
Jahrgang:83
Ausgabe / Heft:12
Erste Seite:1186
Letzte Seite:1192
DOI:https://doi.org/10.1002/pros.24577
Einrichtungen der Universität:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Nuklearmedizin
Nachhaltigkeitsziele
Nachhaltigkeitsziele / Ziel 3 - Gesundheit und Wohlergehen
DDC-Klassifikation:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Lizenz (Deutsch):License LogoCC-BY-NC-ND 4.0: Creative Commons: Namensnennung - Nicht kommerziell - Keine Bearbeitung (mit Print on Demand)